Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpression of polycomb protein BMI-1 in human specimens of breast, ovarian, endometrial and cervical cancer.

Anticancer research - 1 May 2010

Honig A, Weidler C, Häusler S, Krockenberger M, Buchholz S, Köster F, Segerer S E, Dietl J, Engel J B

Abstract excerpt

INTRODUCTION: The polycomb group (PcG) proteins form chromatin-modifying complexes that are commonly deregulated in cancer. The PcG protein BMI-I is overexpressed by various tumours and thus may contribute to malignant transformation. The current study investigated the expression of BMI-I in human specimens of breast, ovarian, endometrial and cervical cancer. MATERIALS AND METHODS: Expression of BMI-I was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin-Dependent Kinase Inhibitor p16
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ki-67 Antigen

Share to Neoplasm Proteins

Share to Ovarian Neoplasms

Share to Polycomb Repressive Complex 1

Share to Proto-Oncogene Proteins

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 20592341

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overexpression of polycomb protein BMI-1 in human specimens of breast, ovarian, endometrial and cervical cancer.PMID 20592341Read ↗

Loss of the human polycomb group protein BMI1 promotes cancer-specific cell deathSemantic proximity Read ↗

BMI1: A Biomarker of Hematologic MalignanciesSemantic proximity Read ↗

Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.Semantic proximity Read ↗

BMI-1, a promising therapeutic target for human cancerSemantic proximity Read ↗

Polycomb group protein Bmi1 expression in colon cancers predicts the survivalSemantic proximity Read ↗

Implication of Polycomb Members Bmi-1, Mel-18, and Hpc-2 in the Regulation of p16INK4a, p14ARF, h-TERT, and c-Myc Expression in Primary Breast CarcinomasSemantic proximity Read ↗

Mutational analysis of Polycomb genes in solid tumours identifies PHC3 amplification as a possible cancer-driving genetic alteration.Semantic proximity Read ↗

Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemiaSemantic proximity Read ↗

Polycomb subunit BMI1 determines uterine progesterone responsiveness essential for normal embryo implantationSemantic proximity Read ↗

Polycomb complexes in normal and malignant hematopoiesisSemantic proximity Read ↗

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer.Semantic proximity Read ↗

Essential Role for Activation of the Polycomb Group (PcG) Protein Chromatin Silencing Pathway in Metastatic Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.